Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF 3rd, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Corkum MT, et al. Among authors: solanki aa. Radiother Oncol. 2023 Jul;184:109672. doi: 10.1016/j.radonc.2023.109672. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059334
Safety practices and opportunities for improvement in brachytherapy: A patient safety practices survey of the American Brachytherapy Society membership.
Sanders JC, Showalter TN, Ouhib Z, Thomadsen BR, Jacob D, Agarwal M, Cohen GN, Giles M, Palaniswammy G, Solanki AA, Taunk NK; Members of the ABS Quality and Safety Committee. Sanders JC, et al. Among authors: solanki aa. Brachytherapy. 2020 Nov-Dec;19(6):762-766. doi: 10.1016/j.brachy.2020.08.014. Epub 2020 Sep 17. Brachytherapy. 2020. PMID: 32952055 Free PMC article.
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer.
Roy S, Zaorsky NG, Bagshaw HP, Berlin A, Tree A, Turner S, Koontz B, Nguyen P, Chen R, Dess RT, Jackson WC, Kishan AU, Stish B, Nagar H, Posadas E, Tran PT, Solanki A, Shore ND, Guo G, Ponsky L, Shoag JE, Morgans AK, Garcia JA, Showalter TN, Feng FY, Spratt DE. Roy S, et al. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):278-289. doi: 10.1016/j.ijrobp.2021.12.005. Epub 2021 Dec 17. Int J Radiat Oncol Biol Phys. 2022. PMID: 34923058 Review.
Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
Solanki AA, Puckett LL, Kujundzic K, Katsoulakis E, Park J, Kapoor R, Hagan M, Kelly M, Palta J, Ballas LK, DeMarco J, Hoffman KE, Lawton CAF, Michalski J, Potters L, Zelefsky M, Kudner R, Dawes S, Wilson E, Sandler H. Solanki AA, et al. Pract Radiat Oncol. 2023 Mar-Apr;13(2):e149-e165. doi: 10.1016/j.prro.2022.08.018. Epub 2022 Dec 9. Pract Radiat Oncol. 2023. PMID: 36522277
Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy.
Venkatesulu B, Giridhar P, Pujari L, Chou B, Lee JH, Block AM, Upadhyay R, Welsh JS, Harkenrider MM, Krishnan S, Verma V, En Hsieh C, Pradhan S, Small W Jr, Solanki AA. Venkatesulu B, et al. Among authors: solanki aa. Radiother Oncol. 2022 Dec;177:81-94. doi: 10.1016/j.radonc.2022.10.019. Epub 2022 Nov 2. Radiother Oncol. 2022. PMID: 36334694 Review.
69 results